Cargando…

Cost‑Effectiveness Risk‑Aversion Curves: Comparison of Risk-Adjusted Performance Measures and Expected-Utility Approaches

Accounting for risk attitudes in medical decision making under uncertainty has attracted little research. A recent proposal recommended using the results of a cost-effectiveness analysis to construct a cost-effectiveness risk-aversion curve (CERAC) to inform risk-averse decision makers choosing amon...

Descripción completa

Detalles Bibliográficos
Autor principal:	Elbasha, Elamin H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Practical Application
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9095517/ https://www.ncbi.nlm.nih.gov/pubmed/35137340 http://dx.doi.org/10.1007/s40273-021-01123-5

Ejemplares similares

Dealing with Bad Risk in Cost-Effectiveness Analysis: The Cost-Effectiveness Risk-Aversion Curve
por: Sendi, Pedram
Publicado: (2020)

One-Way Sensitivity Analysis for Probabilistic Cost-Effectiveness Analysis: Conditional Expected Incremental Net Benefit
por: McCabe, Christopher, et al.
Publicado: (2019)

Different Methods for Modelling Severe Hypoglycaemic Events: Implications for Effectiveness, Costs and Health Utilities
por: Keeney, Edna, et al.
Publicado: (2018)

Standardized Questionnaire for the Measurement, Valuation, and Estimation of Costs of Informal Care Based on the Opportunity Cost and Proxy Good Method
por: Landfeldt, Erik, et al.
Publicado: (2018)

The Broader Opportunity Costs in the Broader Cost-Effectiveness Analysis Framework
por: Vallejo-Torres, Laura
Publicado: (2023)

Risk-Averse Two-Stage Stochastic Minimum Cost Consensus Models with Asymmetric Adjustment Cost
por: Ji, Ying, et al.
Publicado: (2021)

Characterization of the Pharmaceutical Risk-Sharing Arrangement Process in Catalonia
por: Reyes-Travé, Anna, et al.
Publicado: (2021)

Extended Cost-Effectiveness Analysis for Health Policy Assessment: A Tutorial
por: Verguet, Stéphane, et al.
Publicado: (2016)

Geographic Resource Allocation Based on Cost Effectiveness: An Application to Malaria Policy
por: Drake, Tom L., et al.
Publicado: (2017)

The Value of Health in a Cost-Effectiveness Analysis: Theory Versus Practice
por: Wouterse, Bram, et al.
Publicado: (2023)

How Much Should be Invested in Lung Care Across the WHO European Region? Applying a Monetary Value to Disability-Adjusted Life-Years Within the International Respiratory Coalition’s Lung Facts
por: Franklin, Matthew, et al.
Publicado: (2023)

Factors Limiting Subgroup Analysis in Cost-Effectiveness Analysis and a Call for Transparency
por: Shields, Gemma E., et al.
Publicado: (2021)

Impact of a New Cost-Effectiveness Threshold Implementation on Cancer Formulary Decisions in Jordan
por: Treish, Imad, et al.
Publicado: (2021)

Sensitivity Analysis for Not-at-Random Missing Data in Trial-Based Cost-Effectiveness Analysis: A Tutorial
por: Leurent, Baptiste, et al.
Publicado: (2018)

A Guide to Handling Missing Data in Cost-Effectiveness Analysis Conducted Within Randomised Controlled Trials
por: Faria, Rita, et al.
Publicado: (2014)

Estimating Marginal Healthcare Costs Using Genetic Variants as Instrumental Variables: Mendelian Randomization in Economic Evaluation
por: Dixon, Padraig, et al.
Publicado: (2016)

Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon
por: Dahham, Jalal, et al.
Publicado: (2022)

A Simple Cost-Effectiveness Model of Screening: An Open-Source Teaching and Research Tool Coded in R
por: Lin, Yi-Shu, et al.
Publicado: (2023)

Exploring the Integration of Environmental Impacts in the Cost Analysis of the Pilot MEL-SELF Trial of Patient-Led Melanoma Surveillance
por: Williams, Jake T. W., et al.
Publicado: (2022)

Striving for a Societal Perspective: A Framework for Economic Evaluations When Costs and Effects Fall on Multiple Sectors and Decision Makers
por: Walker, Simon, et al.
Publicado: (2019)

Measuring the Benefits of Decision Aids for Economic Evaluation
por: Butt, Thomas
Publicado: (2018)

How to Cost the Implementation of Major System Change for Economic Evaluations: Case Study Using Reconfigurations of Specialist Cancer Surgery in Part of London, England
por: Clarke, Caroline S., et al.
Publicado: (2021)

A Practical Guide to Modeling and Conducting a Cost-Effectiveness Analysis of Companion Biomarker Tests for Targeted Therapies Using R: Tutorial Paper
por: Seo, Mikyung Kelly, et al.
Publicado: (2021)

A Practical Guide for Using Registry Data to Inform Decisions About the Cost Effectiveness of New Cancer Drugs: Lessons Learned from the PHAROS Registry
por: Blommestein, Hedwig M., et al.
Publicado: (2015)

A training paradigm to enhance performance and safe use of an innovative neuroendovascular device
por: Ricci, Donald R., et al.
Publicado: (2016)

Preferred Reporting Items for Studies Mapping onto Preference-Based Outcome Measures: The MAPS Statement
por: Petrou, Stavros, et al.
Publicado: (2015)

Successful Stepwise Development of Patient Research Partnership: 14 Years’ Experience of Actions and Consequences in Outcome Measures in Rheumatology (OMERACT)
por: de Wit, Maarten, et al.
Publicado: (2016)

Risk Aversion, Organ Utilization and Changing Behavior
por: Sharif, Adnan
Publicado: (2022)

Risk aversion in the adjustment of speed-accuracy tradeoff depending on time constraints
por: Onagawa, Ryoji, et al.
Publicado: (2019)

A Promising Approach to Optimizing Sequential Treatment Decisions for Depression: Markov Decision Process
por: Li, Fang, et al.
Publicado: (2022)

Practical Considerations in Using Online Modified-Delphi Approaches to Engage Patients and Other Stakeholders in Clinical Practice Guideline Development
por: Khodyakov, Dmitry, et al.
Publicado: (2019)

Pandemic risk: how large are the expected losses?
por: Fan, Victoria Y, et al.
Publicado: (2018)

An Alternative Approach to Decomposing the Redistributive Effect of Health Financing Between and Within Groups Using the Gini Index: The Case of Out-of-Pocket Payments in Nigeria
por: Ataguba, John E., et al.
Publicado: (2019)

Dynamically adjusting case reporting policy to maximize privacy and public health utility in the face of a pandemic
por: Brown, J Thomas, et al.
Publicado: (2022)

Practical risk-adjusted performance measurement
por: Bacon, Carl R
Publicado: (2013)

New Clinical Insights into Chronic Obstructive Pulmonary Disease and Their Implications for Pharmacoeconomic Analyses
por: Mapel, Douglas W., et al.
Publicado: (2012)

Dealing with Time in Health Economic Evaluation: Methodological Issues and Recommendations for Practice
por: O’Mahony, James F., et al.
Publicado: (2015)

Value-Based Assessment of New Medical Technologies: Towards a Robust Methodological Framework for the Application of Multiple Criteria Decision Analysis in the Context of Health Technology Assessment
por: Angelis, Aris, et al.
Publicado: (2016)

Sample Size Requirements for Discrete-Choice Experiments in Healthcare: a Practical Guide
por: de Bekker-Grob, Esther W., et al.
Publicado: (2015)

EuroQol Protocols for Time Trade-Off Valuation of Health Outcomes
por: Oppe, Mark, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6v4ac10skfr2imc6ue6m9q66da